腺苷酸环化酶1抗体
3'5' cyclic AMP synthetase; ADCY1; adenyl cyclase; Adenylate cyclase 1; adenylate cyclase type I; ATP pyrophosphate lyase; Brain adenylate cyclase 1; Ca(2+)/calmodulin activated adenylyl cyclase; EC 4
磷酸化丝氨酸/苏氨酸蛋白激酶MARK1抗体
MARK1 (phospho T215); MARK 1 (phospho T215); p-MARK1 (phospho T215);KIAA1477; MAP/microtubule affinity regulating kinase 1; MAP/microtubule affinity-regulating kinase 1; MARK 1; MARK; Mark1; MAR
Anti-MYOZ2 Polyclonal Antibody
Anti-MYOZ2 Polyclonal Antibody应用 WB 稀释比例 WB 1:5000-8000. 交叉反应 Human
锚蛋白重复及SAM结构域蛋白3抗体
Ankyrin repeat and SAM domain containing protein 3; Ankyrin repeat and sterile alpha motif domain containing 3; KIAA1977; ANKS3_HUMAN.
少突细胞髓磷脂糖蛋白抗体
olyigodendrocyte myelin glycoprotein; OMG; OMGP; Oligodendrocyte-myelin glycoprotein; OMGP_HUMAN.
黑色素瘤相关抗原3抗体
Antigen MZ2 D; Antigen MZ2-D; Cancer/testis antigen 1.3; Cancer/testis antigen family 1 member 3; CT1.3; HIP8; HYPD; MAGA3_HUMAN; MAGE 3 antigen; MAGE-3 antigen; MAGE3; MAGEA3; MAGEA6; Me
Anti-CP110 Polyclonal Antibody
Anti-CP110 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human